Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
2021/03/01
A delegation led by Li Yunlong, Executive Vice President of the China Association for Pharmaceutical Regulatory Research, visited and inspected Wanbangde Pharmaceutical Group.
Chairman Zhao Shouming inspects the development of Hangzhou's distinctive towns.
The World Federation of Chinese Medicine Geriatrics Annual Conference Held; Wanbangde Products Receive Positive Feedback
Wenling Vice Mayor Chen Xi visits Wanbangde Pharmaceutical Group for an inspection and research visit.
Vice Mayor Xiao Lihui and his delegation from Taizhou City visited and inspected Wanbangde Pharmaceutical Group.
A delegation led by President Lai Maode from China Pharmaceutical University visited and inspected Wanbangde Pharmaceutical Group.
A delegation from the School of Pharmacy at China Pharmaceutical University visits and provides guidance at Wanbangde Pharmaceutical Group.
Wanbangde Pharmaceutical Group and the Shanghai Institute of Materia Medica, CAS, Announce Strategic Collaboration — Signing of the "New Alzheimer's Drug FN12" Project
Wanbande Group expands into Africa's health industry by acquiring South African companies T-Mark and Elite.
Multiple cities in the province jointly launch environmental inspection initiatives.
The State Council's Special Inspection Team on Promoting Private Investment Visits Wanbangde Pharmaceutical Group for an Inspection.
2021/02/06
The "13th Five-Year" plan for the pharmaceutical industry is expected to be released in May.
2021/02/07
Controlling drug prices requires leaving producers with a necessary profit margin.
A list of low-cost drugs may be released within the year, presenting new opportunities for relevant pharmaceutical companies.
Leaders from the Municipal People's Congress visit Wanbande Pharmaceutical Group to inspect the "Five Water Governance" initiative.
